SPAC977.18 Antibody

What is SPAC977.18 and why is it studied in fission yeast research?

SPAC977.18 is a gene found in Schizosaccharomyces pombe (strain 972 / ATCC 24843), commonly known as fission yeast. The protein encoded by this gene is studied as part of fundamental research into eukaryotic cell function and gene expression dynamics. Fission yeast serves as an important model organism in molecular and cell biology research due to its relatively simple genome and eukaryotic cellular organization, allowing researchers to investigate basic biological processes that are often conserved in higher organisms. The SPAC977.18 antibody enables researchers to detect and quantify the corresponding protein in various experimental contexts .

What are the basic specifications of the SPAC977.18 Antibody?

The SPAC977.18 Antibody (product code CSB-PA516833XA01SXV) is a polyclonal antibody raised in rabbits against a recombinant Schizosaccharomyces pombe (strain 972 / ATCC 24843) SPAC977.18 protein. It is provided in liquid form in a buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative. The antibody is affinity-purified and specifically reacts with SPAC977.18 in S. pombe. It has been validated for ELISA and Western Blot applications, making it suitable for protein detection and quantification experiments. The antibody is designated for research use only and should not be used in diagnostic or therapeutic procedures .

How should the SPAC977.18 Antibody be stored and handled?

For optimal preservation of antibody activity, SPAC977.18 Antibody should be stored at -20°C or -80°C immediately upon receipt. Repeated freeze-thaw cycles should be avoided as they can compromise antibody quality and performance. When working with the antibody, it's advisable to aliquot it into smaller volumes before freezing to minimize freeze-thaw cycles. For short-term use, the antibody can be temporarily stored at 4°C. Always centrifuge the vial briefly before opening to ensure the antibody solution is at the bottom of the tube. Handle the antibody with appropriate laboratory practices, including using clean pipette tips and sterile technique to prevent contamination .

What are the validated applications for SPAC977.18 Antibody in fission yeast research?

The SPAC977.18 Antibody has been specifically validated for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) applications. In ELISA, the antibody can be used to detect and quantify SPAC977.18 protein in complex samples, allowing for sensitive measurement of protein levels. In Western Blot applications, the antibody enables visualization of SPAC977.18 protein on immunoblots, providing information about protein expression, molecular weight, and potential post-translational modifications. These techniques are particularly valuable for studying gene expression dynamics, protein regulation, and cellular responses to various experimental conditions in fission yeast .

How can SPAC977.18 Antibody be integrated into temporal gene expression studies?

SPAC977.18 Antibody can be effectively incorporated into temporal gene expression studies by combining protein-level detection with transcriptomic analysis. Researchers can design time-course experiments where both RNA and protein samples are collected at defined intervals following experimental treatments. While RNA samples can be analyzed using techniques such as RNA sequencing or RT-qPCR, protein samples can be processed for Western blot or ELISA using the SPAC977.18 Antibody. This integrated approach allows for comparison between transcriptional and translational responses, providing insights into potential post-transcriptional regulation mechanisms. The MultiRNAflow R package can be used for comprehensive analysis of the temporal transcriptional data, while protein-level data from antibody-based detection can be correlated with gene expression profiles to understand protein-level dynamics .

How should researchers design cross-linking experiments using SPAC977.18 Antibody?

When designing cross-linking experiments with SPAC977.18 Antibody, researchers should first determine the appropriate cross-linking agent based on the specific research question. For protein-protein interactions, formaldehyde (1-2%) or DSS (disuccinimidyl suberate) are commonly used. The cross-linking procedure should be optimized for fission yeast cells, taking into account their cell wall which requires careful consideration of fixation times and conditions. Following cross-linking, cells should be thoroughly washed and lysed using appropriate buffers containing protease inhibitors. Immunoprecipitation can then be performed using the SPAC977.18 Antibody coupled to protein A/G beads or magnetic beads. The immunoprecipitated complexes can be analyzed by mass spectrometry to identify interacting proteins. Control experiments using non-specific IgG should be included to distinguish specific from non-specific interactions. Each step of the protocol should be optimized to ensure efficient cross-linking while maintaining antibody-antigen recognition .

What is the optimal protocol for Western blot using SPAC977.18 Antibody?

For optimal Western blot results with SPAC977.18 Antibody, follow this methodological approach:

Sample Preparation:

• Harvest fission yeast cells during logarithmic growth phase

• Lyse cells in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and protease inhibitor cocktail

• Disrupt cells mechanically using glass beads or enzymatically using zymolyase

• Clear lysate by centrifugation (14,000 × g, 10 minutes, 4°C)

SDS-PAGE and Transfer:

• Separate proteins on 10-12% SDS-PAGE gel (typically 20-40 μg total protein per lane)

• Transfer to PVDF membrane (0.45 μm) at 100V for 60-90 minutes in cold transfer buffer

Antibody Incubation:

• Block membrane with 5% non-fat dry milk in TBST for 1 hour at room temperature

• Incubate with SPAC977.18 Antibody (recommended dilution: 1:500 to 1:2000) overnight at 4°C

• Wash 3× with TBST, 5 minutes each

• Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour at room temperature

• Wash 3× with TBST, 5 minutes each

Detection:

• Apply chemiluminescent substrate and image using appropriate detection system

• Expected molecular weight should be confirmed based on the specific SPAC977.18 protein being studied

Always include positive and negative controls, and optimize antibody concentration for your specific experimental conditions .

How can SPAC977.18 Antibody be used in immunoprecipitation experiments?

For effective immunoprecipitation (IP) using SPAC977.18 Antibody, follow this methodological approach:

Sample Preparation:

• Harvest 50-100 ml of fission yeast culture (OD600 = 0.5-1.0)

• Wash cells with cold PBS and resuspend in IP lysis buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, protease inhibitors)

• Lyse cells using glass beads in a bead beater (8 cycles of 30 seconds, with 1-minute cooling intervals)

• Clear lysate by centrifugation (14,000 × g, 15 minutes, 4°C)

• Pre-clear lysate with Protein A/G beads for 1 hour at 4°C

Immunoprecipitation:

• Add 2-5 μg of SPAC977.18 Antibody to 500-1000 μg of pre-cleared lysate

• Incubate with gentle rotation overnight at 4°C

• Add 30-50 μl of Protein A/G beads and incubate for 2-3 hours at 4°C

• Wash beads 4-5 times with IP wash buffer (same as lysis buffer but with 300 mM NaCl)

• Elute bound proteins by boiling in SDS sample buffer or using gentle elution buffer (0.2 M glycine, pH 2.5)

Analysis:

• Analyze immunoprecipitated proteins by Western blot or mass spectrometry

• Always include a negative control using non-immune rabbit IgG

• For co-IP experiments, blot for potential interacting partners

This protocol can be adapted for chromatin immunoprecipitation (ChIP) by incorporating formaldehyde cross-linking and sonication steps before the IP procedure .

What are the recommended dilutions and controls for ELISA using SPAC977.18 Antibody?

For optimal ELISA performance with SPAC977.18 Antibody, follow these methodological guidelines:

Recommended Dilutions:

Essential Controls:

• Positive Control: Purified recombinant SPAC977.18 protein at known concentrations

• Negative Control: Lysate from SPAC977.18 deletion strain or unrelated protein

• Background Control: Wells with all reagents except primary antibody

• Specificity Control: Pre-absorb antibody with excess antigen before use

• Standard Curve: Serial dilutions of recombinant SPAC977.18 protein

Sample Preparation:
Fission yeast lysates should be prepared using a gentle lysis buffer (PBS with 1% Triton X-100, protease inhibitors) to preserve protein structure and epitope accessibility. For quantitative analysis, normalize samples by total protein concentration using BCA or Bradford assay before performing ELISA .

How can researchers troubleshoot weak or absent signals when using SPAC977.18 Antibody?

When encountering weak or absent signals with SPAC977.18 Antibody, follow this systematic troubleshooting approach:

For Western Blot Issues:

• Protein Extraction Efficiency: Ensure complete cell lysis by optimizing mechanical disruption time or using combination methods (enzymatic plus mechanical). For fission yeast, consider pre-treatment with zymolyase followed by mechanical disruption.

• Protein Denaturation: SPAC977.18 may require specific denaturation conditions. Try varying SDS concentrations (1-2%) and heat treatment times (5-10 minutes at 95°C).

• Antibody Concentration: Increase primary antibody concentration (try 1:250 instead of 1:1000) and extend incubation time to overnight at 4°C.

• Blocking Optimization: Test alternative blocking agents (BSA vs. milk) as some antibodies perform better with specific blockers.

• Enhanced Detection: Use high-sensitivity chemiluminescent substrates or signal enhancement systems.

For ELISA Issues:

• Antibody Activity: Verify antibody activity hasn't been compromised by improper storage or handling.

• Antigen Accessibility: Ensure the epitope is accessible; try alternative sample preparation methods.

• Incubation Conditions: Extend incubation times or adjust temperature to optimize antigen-antibody binding.

• Buffer Compatibility: Test different coating buffers (carbonate/bicarbonate buffer pH 9.6 vs. PBS pH 7.4).

General Considerations:

• Expression Levels: Confirm SPAC977.18 is expressed under your experimental conditions through RT-qPCR.

• Positive Control: Include a known positive sample or recombinant SPAC977.18 protein.

• Protein Modification: Consider whether post-translational modifications might affect antibody recognition under your experimental conditions .

How should researchers interpret contradictory data between protein (antibody-based) and mRNA expression levels of SPAC977.18?

When faced with discrepancies between protein levels (detected using SPAC977.18 Antibody) and mRNA expression data, researchers should consider several biological and technical factors:

Biological Explanations:

• Post-transcriptional Regulation: mRNA may be transcribed but not efficiently translated due to microRNA regulation, RNA binding proteins, or other post-transcriptional mechanisms.

• Protein Stability: SPAC977.18 protein might have distinct degradation rates under different conditions, leading to accumulation or rapid turnover regardless of mRNA levels.

• Temporal Delay: Protein synthesis typically lags behind mRNA expression by several hours. Time-course experiments should account for this delay when comparing datasets.

• Post-translational Modifications: Modifications might affect antibody recognition without changing protein abundance.

Technical Considerations:

• Detection Sensitivity: Western blot and ELISA have different detection thresholds compared to RT-qPCR or RNA-seq.

• Antibody Specificity: Verify the antibody recognizes all forms of the protein (modified, unmodified).

• Data Normalization: Ensure proper normalization for both techniques (housekeeping genes for RNA, loading controls for protein).

Methodological Approach to Reconcile Data:

• Perform time-course experiments with closer time points to capture the transcription-translation relationship.

• Use protein synthesis inhibitors (cycloheximide) or proteasome inhibitors (MG132) to distinguish between synthesis and degradation effects.

• Implement pulse-chase experiments to determine protein half-life.

• Consider using the MultiRNAflow R package for integrated analysis of temporal transcriptional responses alongside protein data.

The discrepancy itself may represent an important biological finding about SPAC977.18 regulation in fission yeast that warrants further investigation .

How can researchers quantify SPAC977.18 protein levels accurately for comparative studies?

For accurate quantification of SPAC977.18 protein levels in comparative studies, researchers should implement the following methodological approach:

Western Blot Quantification:

• Standard Curve Method: Include a dilution series of recombinant SPAC977.18 protein (5-7 points) on each blot to create a standard curve.

• Internal Loading Control: Simultaneously probe for a stable reference protein (e.g., α-tubulin, GAPDH) that doesn't change under your experimental conditions.

• Technical Replicates: Perform at least three technical replicates of each biological sample.

• Image Acquisition: Use a digital imaging system with a wide dynamic range (e.g., CCD camera-based systems) rather than film.

• Quantification Software: Use specialized software (ImageJ, Image Studio, etc.) to quantify band intensities within the linear range of detection.

ELISA Quantification:

• Standard Curve: Generate a standard curve using purified recombinant SPAC977.18 protein (8-12 dilution points).

• Four-Parameter Logistic Regression: Use 4-PL curve fitting rather than linear regression for more accurate quantification, especially at lower and upper detection limits.

• Sample Dilutions: Test multiple dilutions of each sample to ensure readings fall within the linear range of the standard curve.

• Spike Recovery Tests: Add known amounts of recombinant protein to samples to assess matrix effects.

Normalization Strategies:

• Total Protein Normalization: Use total protein stains (SYPRO Ruby, Ponceau S) as an alternative to housekeeping proteins.

• Multiple Reference Genes: When normalizing to loading controls, use multiple reference proteins and calculate geometric means.

Statistical Analysis:

• Perform at least three biological replicates for each condition.

• Use appropriate statistical tests (t-test for two conditions, ANOVA for multiple conditions).

• Report both fold change and statistical significance (p-values).

This comprehensive approach ensures reliable quantification for comparing SPAC977.18 protein levels across different experimental conditions .

How can SPAC977.18 Antibody be integrated with temporal clustering analysis in fission yeast research?

Integrating SPAC977.18 Antibody detection with temporal clustering analysis provides a powerful approach to understanding gene expression dynamics. This methodological strategy combines protein-level data with transcriptomic analysis:

• Experimental Design: Design time-course experiments with samples collected at strategic timepoints (e.g., 0, 15, 30, 60, 120, 240 minutes after treatment). For each timepoint, collect parallel samples for both RNA extraction and protein analysis.

• Transcriptomic Analysis:

  • Process RNA samples for RNA-seq or microarray analysis

  • Use the MultiRNAflow R package, specifically the MFUZZanalysis() function, to identify clusters of co-expressed genes over time

  • Identify which temporal expression cluster SPAC977.18 belongs to and its co-expressed genes

• Protein-Level Validation:

  • Process protein samples for Western blot or ELISA using SPAC977.18 Antibody

  • Quantify protein levels across the time course

  • Compare protein dynamics to mRNA expression patterns

• Integrated Analysis:

  • Create overlapping visualizations of mRNA and protein levels using DATAplotExpressionGenes() function

  • Calculate correlation coefficients between mRNA and protein temporal profiles

  • Identify potential time lags between transcription and translation

• Biological Network Reconstruction:

  • Use protein interaction data from co-immunoprecipitation with SPAC977.18 Antibody

  • Integrate this with co-expression networks from temporal clustering

  • Build a comprehensive regulatory model incorporating both transcriptional and protein-level interactions

This integrated approach allows researchers to distinguish between transcriptional and post-transcriptional regulation and identify key regulatory points in response to experimental conditions .

What approaches can researchers use to study post-translational modifications of SPAC977.18 protein?

To comprehensively study post-translational modifications (PTMs) of SPAC977.18 protein, researchers can implement these advanced methodological approaches:

Immunoprecipitation-Based Detection:

• Perform immunoprecipitation using SPAC977.18 Antibody under non-denaturing conditions

• Subject immunoprecipitated protein to:

  • Western blot with PTM-specific antibodies (anti-phospho, anti-ubiquitin, anti-SUMO, etc.)

  • Mass spectrometry analysis for unbiased PTM identification

Mass Spectrometry Workflow:

• Sample Preparation: Immunoprecipitate SPAC977.18 protein using the antibody

• Digestion Strategy: Perform parallel digestions with multiple proteases (trypsin, chymotrypsin, Glu-C) to maximize sequence coverage

• Enrichment Methods:

  • Phosphopeptide enrichment: TiO₂ or IMAC (immobilized metal affinity chromatography)

  • Ubiquitination: K-ε-GG antibody enrichment after trypsin digestion

  • Glycosylation: Lectin affinity chromatography or hydrazide chemistry

• MS Analysis:

  • Use high-resolution MS/MS with electron transfer dissociation (ETD) or higher-energy collisional dissociation (HCD)

  • Implement parallel reaction monitoring (PRM) for targeted quantification of modified peptides

Site-Specific Mutation Studies:

• Identify putative modification sites from MS data or sequence-based prediction

• Generate fission yeast strains with site-specific mutations (e.g., S→A for phosphorylation, K→R for ubiquitination)

• Analyze phenotypic consequences and protein function

Temporal Dynamics of PTMs:

• Design time-course experiments to monitor changes in PTMs following specific stimuli

• Quantify modification stoichiometry at each timepoint using MS or PTM-specific antibodies

• Correlate with protein activity or localization changes

Inhibitor Studies:

• Use specific inhibitors of PTM enzymes (kinase inhibitors, deubiquitinase inhibitors, etc.)

• Monitor effects on SPAC977.18 modification state, stability, and function

These approaches, used in combination, provide comprehensive insights into the PTM landscape of SPAC977.18 and its functional significance in fission yeast biology .

How can researchers utilize SPAC977.18 Antibody in chromatin immunoprecipitation (ChIP) experiments?

For effective chromatin immunoprecipitation (ChIP) experiments using SPAC977.18 Antibody, researchers should follow this detailed methodological approach:

Experimental Design Considerations:

• Cell Number Optimization: Start with approximately 1-2 × 10⁸ fission yeast cells per ChIP reaction. Scale based on protein abundance—lower abundance may require more cells.

• Crosslinking Conditions: Optimize formaldehyde concentration (1-1.5%) and time (10-15 minutes at room temperature) specifically for fission yeast, which has a cell wall that can impede fixative penetration.

• Controls: Include input DNA (pre-immunoprecipitation), negative control (non-specific IgG), and positive control (histone antibody) in each experiment.

Protocol Steps:

• Crosslinking and Cell Lysis:

  • Treat cells with formaldehyde (1% final concentration, 10 minutes at room temperature)

  • Quench with 125 mM glycine for 5 minutes

  • Harvest cells and wash twice with cold PBS

  • Resuspend in lysis buffer containing protease inhibitors

  • Lyse cells using glass beads in a bead beater (8 cycles of 30 seconds, with 1-minute cooling intervals)

• Chromatin Preparation:

  • Sonicate lysate to generate DNA fragments of 200-500 bp

  • Verify fragment size by agarose gel electrophoresis

  • Pre-clear chromatin with Protein A/G beads for 1 hour at 4°C

• Immunoprecipitation:

  • Incubate pre-cleared chromatin with 2-5 μg SPAC977.18 Antibody overnight at 4°C

  • Add Protein A/G beads and incubate for 2-3 hours at 4°C

  • Wash beads with increasingly stringent buffers:

    • Low salt wash buffer (150 mM NaCl)

    • High salt wash buffer (500 mM NaCl)

    • LiCl wash buffer (0.25 M LiCl)

    • TE buffer (twice)

• DNA Recovery and Analysis:

  • Elute DNA-protein complexes from beads with elution buffer (1% SDS, 0.1 M NaHCO₃)

  • Reverse crosslinks overnight at 65°C

  • Treat with RNase A and Proteinase K

  • Purify DNA using phenol-chloroform extraction or commercial kits

  • Analyze by qPCR, ChIP-seq, or ChIP-chip

Analytical Considerations:

• ChIP-qPCR: Design primers for suspected binding regions and control regions

• ChIP-seq: Use appropriate library preparation methods optimized for low DNA input

• Data Analysis: Implement peak calling algorithms appropriate for transcription factors or chromatin modifiers depending on SPAC977.18's function

• Data Integration: Integrate ChIP data with RNA-seq data to correlate binding with gene expression

This protocol enables researchers to identify DNA-binding sites and potential gene targets of SPAC977.18 if it functions as a DNA-binding protein or associates with chromatin .

How can researchers compare SPAC977.18 function between different yeast species or strains?

To conduct effective comparative studies of SPAC977.18 function across different yeast species or strains, researchers should implement the following methodological approach:

Bioinformatic Analysis:

• Sequence Homology Search: Identify orthologs of SPAC977.18 in other yeast species (S. cerevisiae, C. albicans, etc.) using BLAST, HMMer, or specialized orthology databases.

• Protein Domain Analysis: Compare conserved domains and motifs using tools like InterPro, Pfam, or SMART to predict functional conservation.

• Evolutionary Rate Analysis: Calculate Ka/Ks ratios to determine selective pressure on different regions of the protein.

Cross-Species Antibody Validation:

• Epitope Conservation Assessment: Analyze sequence conservation of the immunogen region used to generate the SPAC977.18 Antibody.

• Cross-Reactivity Testing: Test the antibody against lysates from various yeast species using Western blot.

• Specificity Confirmation: Include appropriate controls (knockout strains if available) to confirm specificity in each species.

Functional Complementation Experiments:

• Gene Deletion/Replacement: Generate deletion mutants in S. pombe and other yeast species for the SPAC977.18 ortholog.

• Cross-Species Complementation: Express SPAC977.18 orthologs from different species in the S. pombe deletion strain.

• Phenotypic Analysis: Compare growth rates, morphology, stress responses, and other relevant phenotypes.

Comparative Expression Analysis:

• Standard Growth Conditions: Analyze expression levels across species under identical growth conditions using the antibody (Western blot) and mRNA quantification (RT-qPCR).

• Stress Responses: Compare expression changes in response to various stressors (heat, oxidative stress, nutrient limitation).

• Cell Cycle Regulation: Synchronize cultures and assess expression dynamics throughout the cell cycle.

Protein Interaction Networks:

• Immunoprecipitation: Use the SPAC977.18 Antibody for IP-MS studies in different species (where cross-reactivity is confirmed).

• Comparative Interactomics: Compare protein interaction partners across species to identify conserved and species-specific interactions.

• Network Analysis: Construct and compare protein interaction networks to infer functional conservation or divergence.

This comprehensive approach enables researchers to understand evolutionary conservation and divergence of SPAC977.18 function, providing insights into fundamental biological processes conserved across yeast species .

What methodologies can researchers use to integrate SPAC977.18 protein data with transcriptomic datasets?

For effective integration of SPAC977.18 protein data with transcriptomic datasets, researchers should implement these advanced methodological approaches:

Data Collection and Preprocessing:

• Synchronized Sampling: Collect protein and RNA samples simultaneously from the same cell populations to minimize variation.

• Multiple Timepoints: Implement time-course experiments with sufficient temporal resolution to capture dynamics (e.g., 6-8 timepoints).

• Normalization Strategies:

  • For protein data: Normalize to total protein or stable reference proteins

  • For RNA data: Implement appropriate normalization methods (TPM, RPKM, or DESeq2 normalization)

  • Consider batch effect correction if samples are processed in different batches

Integration Analysis Workflow:

• Correlation Analysis:

  • Calculate Pearson or Spearman correlation between SPAC977.18 mRNA and protein levels across conditions

  • Implement time-lagged correlation analysis to account for delays between transcription and translation

  • Compare correlation patterns with global mRNA-protein correlation distribution

• MultiRNAflow Package Implementation:

  • Use the DATAprepSE() function for preprocessing RNA-seq data

  • Apply DATAnormalization() to normalize expression data

  • Implement PCAanalysis() and HCPCanalysis() for dimensional reduction and clustering

  • Use MFUZZanalysis() for temporal clustering of gene expression patterns

  • Integrate protein data by correlating with expression clusters

  • Visualize SPAC977.18 expression profiles using DATAplotExpressionGenes()

• Multivariate Statistical Approaches:

  • Implement Canonical Correlation Analysis (CCA) to identify relationships between protein and transcriptome datasets

  • Apply Partial Least Squares (PLS) regression to model relationships between datasets

  • Consider tensor-based methods for three-dimensional data (conditions × time × molecular level)

• Network-Based Integration:

  • Construct gene co-expression networks from transcriptome data

  • Integrate protein interaction data from SPAC977.18 immunoprecipitation experiments

  • Identify network modules where SPAC977.18 plays a central role

  • Use pathway enrichment analysis to interpret biological significance

• Causal Inference Modeling:

  • Implement Granger causality analysis to infer temporal causal relationships

  • Apply Dynamic Bayesian Networks to model regulatory relationships over time

  • Use Structural Equation Modeling to test hypothesized causal structures

This integrated approach provides comprehensive insights into the relationship between SPAC977.18 transcription, translation, and function within the broader cellular context .

What emerging technologies might enhance SPAC977.18 protein research beyond antibody-based detection?

Several cutting-edge technologies offer new possibilities for SPAC977.18 protein research that complement or extend beyond traditional antibody-based approaches:

CRISPR-Based Tagging Systems:

• Endogenous Tagging: CRISPR-Cas9-mediated knock-in of fluorescent proteins (GFP, mCherry) or affinity tags (FLAG, HA, HiBiT) to the endogenous SPAC977.18 locus provides native expression level visualization and purification options.

• CasMINI Systems: Smaller Cas variants enable multi-color tagging for simultaneous tracking of SPAC977.18 and interaction partners.

• Temporal Control: Implement auxin-inducible degron (AID) tags for rapid, reversible protein depletion to study acute loss of function.

Proximity Labeling Technologies:

• TurboID/miniTurbo: Fusion of biotin ligase to SPAC977.18 enables proximity-dependent biotinylation of interacting proteins, capturing even transient interactions not detectable by traditional co-IP.

• APEX2 System: Peroxidase-based proximity labeling provides millisecond-scale temporal resolution and subcellular compartment specificity.

• Split-BioID: Enables detection of specific protein-protein interactions through reconstitution of split biotin ligase activity.

Single-Molecule Approaches:

• Single-Molecule Tracking: Using HaloTag or SNAP-tag fusions to SPAC977.18 for live-cell imaging with organic fluorophores provides insights into protein dynamics and diffusion properties.

• Super-Resolution Microscopy: Techniques like PALM, STORM, or STED can resolve SPAC977.18 localization at nanometer-scale resolution.

• smFRET: Single-molecule Förster resonance energy transfer can detect conformational changes in SPAC977.18 upon binding partners or substrates.

Mass Spectrometry Innovations:

• Thermal Proteome Profiling (TPP): Detects protein-ligand interactions and protein complex formation through changes in thermal stability.

• Protein Correlation Profiling: Combines biochemical fractionation with quantitative proteomics to map protein complexes and subcellular localization.

• Cross-linking Mass Spectrometry (XL-MS): Identifies direct protein-protein interaction interfaces at amino acid resolution.

• Data-Independent Acquisition (DIA-MS): Provides more comprehensive and reproducible protein quantification than traditional data-dependent acquisition.

Proteogenomic Integration:

• Optical Pooled Screens: Combining CRISPR perturbations with imaging readouts to assess SPAC977.18 function in high-throughput.

• Ribo-seq Integration: Coupling ribosome profiling with proteomics to study SPAC977.18 translation regulation.

• Single-Cell Multi-omics: Simultaneous measurement of transcriptome, proteome, and phenotype in single cells to capture heterogeneity in SPAC977.18 expression and function.

These emerging technologies offer unprecedented resolution in studying SPAC977.18 protein dynamics, interactions, and functions in fission yeast, potentially revealing new biological insights beyond what traditional antibody-based methods can provide .

How might researchers design experiments to study the regulation of SPAC977.18 during cell cycle progression?

To comprehensively investigate SPAC977.18 regulation during cell cycle progression in fission yeast, researchers should design experiments using the following methodological framework:

Cell Synchronization Strategies:

• Nitrogen Starvation and Release: Induce G1 arrest by nitrogen deprivation (16-24 hours), then release into nitrogen-rich medium.

• Hydroxyurea Block and Release: Synchronize cells in early S phase using hydroxyurea (11-12 mM for 4 hours), then release by washing.

• Temperature-Sensitive cdc Mutants: Use temperature-sensitive cell division cycle mutants (e.g., cdc25-22) that arrest at specific cell cycle stages when shifted to restrictive temperature.

• Size Selection by Centrifugal Elutriation: Physically separate cells based on size to obtain populations enriched in G2 phase.

Time-Course Sampling Design:

• Take samples every 15-20 minutes for 3-4 hours to cover a complete cell cycle

• Monitor synchrony using flow cytometry (DNA content) and microscopy (septation index)

• Split samples for parallel analysis of:

  • Protein levels (Western blot with SPAC977.18 Antibody)

  • mRNA expression (RT-qPCR or RNA-seq)

  • Post-translational modifications (IP-MS)

  • Subcellular localization (immunofluorescence)

  • Chromatin association (ChIP if applicable)

Regulatory Mechanism Analysis:

• Transcriptional Regulation:

  • Perform promoter analysis to identify cell cycle-regulated elements

  • Use reporter constructs with SPAC977.18 promoter driving fluorescent protein expression

  • Identify transcription factors using ChIP with candidate regulators

• Post-Transcriptional Control:

  • Assess mRNA stability using transcription inhibition (1,10-phenanthroline) followed by RT-qPCR

  • Analyze 3'UTR-mediated regulation using reporter constructs with SPAC977.18 3'UTR

  • Investigate RNA-binding proteins using RNA immunoprecipitation

• Translational Control:

  • Examine polysome profiles to assess translation efficiency across the cell cycle

  • Use ribosome profiling to quantify ribosome occupancy on SPAC977.18 mRNA

• Post-Translational Regulation:

  • Monitor PTMs using phospho-specific antibodies or mass spectrometry

  • Identify responsible kinases/phosphatases using inhibitors or genetic approaches

  • Create non-modifiable mutants (e.g., phospho-null, phospho-mimetic) to assess functional significance

  • Measure protein half-life across cell cycle using cycloheximide chase experiments

Data Integration and Modeling:

• Integrate all datasets using the MultiRNAflow R package for comprehensive analysis

• Develop mathematical models of SPAC977.18 regulation incorporating transcriptional, post-transcriptional, and post-translational mechanisms

• Validate the model by predicting SPAC977.18 behavior under perturbed conditions

This experimental design provides a comprehensive view of SPAC977.18 regulation throughout the cell cycle, revealing the relative contributions of different regulatory mechanisms to its cell cycle-dependent expression pattern .

What are the key considerations for designing rigorous control experiments when working with SPAC977.18 Antibody?

Designing rigorous control experiments is critical for ensuring reliable and interpretable results when working with SPAC977.18 Antibody. Researchers should incorporate multiple levels of controls addressing specificity, technical variation, and biological relevance:

Antibody Specificity Controls:

• Genetic Validation: Include samples from SPAC977.18 deletion strains (when possible) as negative controls in Western blot and immunoprecipitation experiments.

• Competitive Inhibition: Pre-incubate the antibody with excess recombinant SPAC977.18 protein before application to demonstrate binding specificity.

• Secondary Antibody-Only Control: Include samples treated with secondary antibody but no primary antibody to identify non-specific binding of the secondary antibody.

• Isotype Control: Use non-specific rabbit IgG at the same concentration as SPAC977.18 Antibody to distinguish specific from non-specific binding.

Technical Controls:

• Loading Controls: Include stable reference proteins (α-tubulin, GAPDH) in Western blots to normalize for loading variations.

• Standard Curve: Include a dilution series of recombinant SPAC977.18 protein to ensure detection is within the linear range.

• Replicate Types: Incorporate both technical replicates (same biological sample) and biological replicates (independent samples) to assess variation sources.

• Batch Controls: Process control samples alongside experimental samples when experiments span multiple days to account for day-to-day variations.

Experimental Design Controls:

• Time-course Zero Point: Include a t=0 sample before any treatment to establish baseline expression levels.

• Vehicle Control: When applying treatments dissolved in specific solvents (DMSO, ethanol), include vehicle-only controls.

• Positive Response Control: Include a condition known to affect SPAC977.18 expression or modification to validate experimental sensitivity.

• Wild-type Control: When using mutant strains, always include the isogenic wild-type strain processed identically.

Validation Through Orthogonal Methods:

• Alternative Detection Methods: Validate key findings using alternative approaches (e.g., validate Western blot findings with mass spectrometry).

• Independent Antibodies: When possible, confirm critical results using antibodies recognizing different epitopes of SPAC977.18.

• Tagged Protein Approach: Compare results with epitope-tagged versions of SPAC977.18 (HA, FLAG, etc.) detected with well-characterized tag antibodies.

By implementing these comprehensive control strategies, researchers can establish confidence in their SPAC977.18 Antibody-based findings and facilitate robust interpretation of experimental results in the context of fission yeast biology .

What future research questions about SPAC977.18 in fission yeast remain to be addressed?

Despite the valuable research tools available for studying SPAC977.18, several critical research questions remain unexplored, presenting opportunities for future investigations:

Functional Characterization:

• What is the precise molecular function of SPAC977.18 in fission yeast cellular processes? Does it serve as an enzyme, structural protein, or regulatory factor?

• How does SPAC977.18 contribute to cellular fitness under various environmental stress conditions (oxidative stress, nutrient limitation, temperature shift)?

• What phenotypes emerge from SPAC977.18 deletion, overexpression, or conditional depletion?

Regulatory Networks:

• What upstream signaling pathways regulate SPAC977.18 expression and activity?

• Which transcription factors directly control SPAC977.18 gene expression?

• How is SPAC977.18 protein level regulated post-transcriptionally and post-translationally during different cellular states?

Protein Interactions and Complexes:

• What are the direct protein interaction partners of SPAC977.18 and do these interactions change dynamically?

• Does SPAC977.18 function as part of a stable multi-protein complex or through transient interactions?

• How do post-translational modifications affect SPAC977.18 protein-protein interactions?

Subcellular Localization and Dynamics:

• What is the subcellular localization of SPAC977.18 and does it change under specific conditions?

• Does SPAC977.18 shuttle between different cellular compartments?

• How dynamic is SPAC977.18 turnover and what factors influence its stability?

Evolutionary Conservation:

• How conserved is SPAC977.18 function across different yeast species and potentially higher eukaryotes?

• If SPAC977.18 has orthologs in other organisms, have they diverged functionally or maintained ancestral roles?

• What can comparative genomics reveal about the evolutionary history of SPAC977.18?

Disease Relevance:

• Do human orthologs of SPAC977.18 exist, and if so, are they implicated in human diseases?

• Can fission yeast SPAC977.18 serve as a model for studying functions of related proteins in higher eukaryotes?

• Could SPAC977.18 or its interactors represent potential therapeutic targets for diseases affecting conserved cellular processes?

Technological Advances:

• How can emerging technologies (CRISPR, proximity labeling, single-molecule imaging) be optimized for studying SPAC977.18?

• Can computational models accurately predict SPAC977.18 behavior under various conditions?

• What high-throughput approaches could identify genetic interactions and synthetic phenotypes associated with SPAC977.18?